Concepedia

Abdulhamied Alfaddagh

AA

14

Publications

412

Citations

12

H-Index

2012

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Johns Hopkins University

Johns Hopkins Medicine

Kuwait University

Abdulhamied Alfaddagh is an author at Beth Israel Deaconess Medical Center specializing in cardiovascular disease, public health, and atherosclerosis.

ORCID

Top concepts

Publications per year

2012–2023

14

Publications

14

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial

Abdulhamied Alfaddagh, Tarec K. Elajami, Hasan Ashfaque et al. · Journal of the American Heart Association · 2017 · 89 citations · Full text

Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B <sub>4</sub>

Francine K. Welty, Fabian Schulte, Abdulhamied Alfaddagh et al. · The FASEB Journal · 2021 · 53 citations · Full text

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Tarec K. Elajami, Abdulhamied Alfaddagh, Dharshan Lakshminarayan et al. · Journal of the American Heart Association · 2017 · 48 citations · Full text

An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment

Abdulhamied Alfaddagh, Tarec K. Elajami, Mohamad Saleh et al. · Atherosclerosis · 2019 · 47 citations · Full text

, , +7

The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial

Abdulhamied Alfaddagh, Tarec K. Elajami, Mohamad Saleh et al. · Journal of clinical lipidology · 2018 · 24 citations · Full text

, , +9

Rows per page

1–5 of 14